EUVIMEDEUVIMED entdecken
Open Access

TIE2 links MEKK3–KLF2/4 and PI3K signaling in cerebral cavernous malformation

Lun Li iD, Marco Castro iD, Hiroki Hongo iD, Jian Ren iD, Robert Shenkar iD, Rashad Jabarkheel iD, Siqi Gao iD, Sweta Narayan iD, Maxwell Frankfurter iD, Alan T Tang iD, Jisheng Yang iD, Mei Chen iD und 15 weitere

Journal of Experimental Medicine · 2026

DOI: 10.1084/jem.20251374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Lun Li und 26 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Institute and Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Kruppel-Like Transcription Factors, MAP Kinase Kinase Kinase 3, Receptor, TIE-2, Hemangioma, Cavernous, Central Nervous System. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Adelman CCM, NINDS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral cavernous malformations (CCMs) are vascular lesions in the central nervous system that can cause strokes and seizures. Aggressive CCM growth follows an endothelial cell two-hit mechanism in which enhanced MEKK3–KLF2/4 signaling stimulates PI3K signaling, but how these pathways are linked has been undefined. Here, we use human CCM specimens, two mouse models of CCM disease, and primary human endothelial cells to examine the roles of the major endothelial growth factor receptors, VEGFR2 and TIE2. We find no evidence of augmented VEGFR2 signaling in CCM lesions, and neither genetic nor pharmacologic blockade of VEGFR2 reduced CCM formation in mouse models. Instead, we observe markedly increased phospho-TIE2 levels in human and mouse CCM lesions, MEKK3–KLF2/4-driven induction of TIE2 receptor expression, and almost complete rescue of CCM formation following genetic or pharmacologic TIE2 blockade in mouse models. Our studies identify TIE2 as the molecular link between the MEKK3–KLF2/4 and PI3K signaling pathways during CCM formation and suggest that targeting TIE2 may be an effective means to treat human CCM disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kruppel-Like Transcription FactorsMAP Kinase Kinase Kinase 3Receptor, TIE-2Hemangioma, Cavernous, Central Nervous SystemPhosphatidylinositol 3-KinasesSignal TransductionAnimalsHumansMiceKruppel-Like Factor 4Endothelial CellsDisease Models, AnimalVascular Endothelial Growth Factor Receptor-2

Substanzen

Kruppel-Like Transcription FactorsMAP Kinase Kinase Kinase 3Receptor, TIE-2Phosphatidylinositol 3-KinasesKruppel-Like Factor 4Klf4 protein, mouseKLF4 protein, humanKlf2 protein, mouseKLF2 protein, humanVascular Endothelial Growth Factor Receptor-2

Autor:innen und Institutionen

  • Cardiovascular Institute and Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Neurosurgery, Perelman School of Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, PA, USA.
  • Angiogenesis & Metabolism Laboratory, Center of Vascular Biomedicine, Berlin Institute of Health at Charité - Universitätsmedizin Berlin , Berlin, Germany.
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association , Berlin, Germany.
  • Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Neurosurgery, Xuanwu Hospital, China International Neuroscience Institute, National Center for Neurological Disorders, Capital Medical University, Beijing, China.

ORCID-Profile: Lun Li, Marco Castro, Hiroki Hongo, Jian Ren, Robert Shenkar, Rashad Jabarkheel, Siqi Gao, Sweta Narayan, Maxwell Frankfurter, Alan T Tang, Jisheng Yang, Mei Chen, Jenna Bockman, Patricia Mericko-Ishizuka, Roberto Alcazar, Georgio Sader, Javed Iqbal, Serena Kinkade, Rhonda Lightle, Andrew K Ressler, Xianghu Qu, H Scott Baldwin, Douglas A Marchuk, Issam A Awad, Jan-Karl Burkhardt, Michael Potente, Mark L Kahn

Förderung

  • Adelman CCM
  • NINDS NIH HHS
  • NIH HHS
  • Leducq Foundation
  • NHLBI NIH HHS
  • German Center for Cardiovascular Research
  • AHA Postdoctoral Fellowship
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Li, L., Castro, M., Hongo, H., Ren, J., Shenkar, R., Jabarkheel, R., Gao, S., Narayan, S., Frankfurter, M., Tang, A. T., Yang, J., Chen, M., Bockman, J., Mericko-Ishizuka, P., Alcazar, R., Sader, G., Iqbal, J., Kinkade, S., Lightle, R., …, & Kahn, M. L. (2026). TIE2 links MEKK3–KLF2/4 and PI3K signaling in cerebral cavernous malformation. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20251374

Vancouver

Li L, Castro M, Hongo H, Ren J, Shenkar R, Jabarkheel R, et al. TIE2 links MEKK3–KLF2/4 and PI3K signaling in cerebral cavernous malformation. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20251374

BibTeX
@article{Li2026,
  author = {Li, Lun and Castro, Marco and Hongo, Hiroki and Ren, Jian and Shenkar, Robert and Jabarkheel, Rashad and Gao, Siqi and Narayan, Sweta and Frankfurter, Maxwell and Tang, Alan T and Yang, Jisheng and Chen, Mei and Bockman, Jenna and Mericko-Ishizuka, Patricia and Alcazar, Roberto and Sader, Georgio and Iqbal, Javed and Kinkade, Serena and Lightle, Rhonda and Ressler, Andrew K and Qu, Xianghu and Baldwin, H Scott and Marchuk, Douglas A and Awad, Issam A and Burkhardt, Jan-Karl and Potente, Michael and Kahn, Mark L},
  title = {TIE2 links MEKK3–KLF2/4 and PI3K signaling in cerebral cavernous malformation},
  journal = {Journal of Experimental Medicine},
  year = {2026},
  doi = {10.1084/jem.20251374}
}
Kostenlos starten →